UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|||||
FORM
8-K
|
|||||
CURRENT
REPORT
|
|||||
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|||||
Date
of Report (date of earliest event reported): September 19,
2007
|
|||||
AMS
HEALTH SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
|
|||||
OKLAHOMA
(State
or other jurisdiction of incorporation)
|
001−13343
(Commission
File Number)
|
73-1323256
(I.R.S.
Employer Identification No.)
|
|||
711
NE 39th Street,
Oklahoma City, OK
(Address
of principal executive offices)
|
73105
(Zip
Code)
|
||||
Registrant’s
telephone number, including area
code: (405)
842-0131
|
|||||
Not
Applicable
(Former
name or former address, if changed since last report.)
|
|||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any
of the following provisions:
|
|||||
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
||||
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
||||
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
||||
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13a-4(c))
|
Item
3.01
|
Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard;
Transfer of Listing.
|
|
·
|
AMS
had stockholders’ equity of less than $2 million and had sustained losses
from continuing operations and net losses in two of its three most
recent
fiscal years, as a result of which AMS was not in compliance with
Section
1003(a)(i) of the Amex Company
Guide;
|
|
·
|
AMS
had stockholders’ equity of less than $4 million and had sustained losses
from continuing operations and net losses in three of its four
most recent
fiscal years, as a result of which AMS was not in compliance with
Section
1003(a)(ii) of the Amex Company
Guide;
|
|
·
|
AMS
had stockholders’ equity of less than $6 million and had sustained losses
from continuing operations and net losses in its five most recent
fiscal
years, as a result of which AMS was not in compliance with Section
1003(a)(iii) of the Amex Company
Guide.
|
|
·
|
Certain
institutional investors have policies against investments in bulletin
board companies and other investors may refrain from purchasing
AMS’s
securities because they are no longer listed on a national securities
exchange; and/or
|
|
·
|
AMS’s
ability to sell its equity and debt securities in direct or underwritten
offerings will be more limited in numerous states because it will
no
longer benefit from state exemptions from registration based upon
its
listing on the
Amex.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
AMS
HEALTH SCIENCES, INC.
|
||
(Registrant)
|
||
Date: September
21, 2007
|
By:
|
/s/
Robin L. Jacob
|
Robin
L. Jacob
|
||
Vice
President and Chief Financial
Officer
|
Exhibit
Number
|
|
Exhibit Description
|
99.1*
|
|
Press
Release dated September 19, 2007.
|